نمایش پرونده ساده آیتم

dc.contributor.advisorMalek Mahdavi, Aida
dc.contributor.authorAghamohammadi, Ramin
dc.date.accessioned2019-07-30T06:02:22Z
dc.date.available2019-07-30T06:02:22Z
dc.date.issued2019en_US
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/60350
dc.description.abstractThis case-control study was conducted to investigate the association between smoking and the risk of BD. Methods: We included 192 patients with BD and 822 healthy siblings of patient with BD and 373 healthy unrelated persons as control groups. Demographic data and smoking history of patients and their siblings were obtained by direct and in some cases by telephone interview with the participants. Demographic data and smoking history of healthy controls were obtained by direct interview. Short Form-36 Quality of Life Scale (SF-36) was used to evaluate QoL. Propensity score matching (PSM) analyses for reducing the heterogeneity between studied groups and calculating the actual effect of smoking in BD was performed. Matching was performed based on demographic characteristics (age, gender, educational status and marital status). After propensity score matching, we carried out multivariate analyses with BD as the main outcome variable and smoking history as the main predictor variable to calculate odds ratios with 95% confidence intervals. Results: Ever smoking was not significantly associated with an increased risk of BD compared with never smoking. In comparison with healthy siblings and healthy unrelated persons, the relative risk of developing BD was 0.6-2.8 No significant differences were observed in the clinical manifestations of BD patients in ever smokers and never smokers. However, disease activity in ever smokers at disease presentation was significantly more than never smokers. The Physical Health score as well as most of SF-36 domains including Role Physical, Bodily Pain, General Health, Vitality, and Mental Health were significantly lower in BD patients compared with the control group(P<0.05). There was no significant difference in SF-36 quality of life scores (P>0.05) between smokers and non-smokers BD patients except for Role Emotion item. There was no significant correlation between smoking status and SF-36 quality of life scores (P>0.05).en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, Faculty of Medicineen_US
dc.subjectBehçet's Diseaseen_US
dc.subjectCigaretteen_US
dc.subjectDisease Activityen_US
dc.subjectQuality of Lifeen_US
dc.titleComparison of smoking status between Behçet patients and healthy subjects and its relationship with clinical manifestations, disease activity and quality of life in patients with Behçet’s diseaseen_US
dc.typeThesisen_US
dc.contributor.supervisorKhabbazi, Alireza
dc.identifier.docno609199en_US
dc.identifier.callno9199en_US
dc.description.disciplineInternal Medicineen_US
dc.description.degreeSpecialty Degreeen_US


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم